Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt.

Drug and alcohol dependence - 1 Jun 2015

Ware Jennifer J, Aveyard Paul, Broderick Peter, Houlston Richard S, Eisen Timothy, Munafò Marcus R

Abstract excerpt

INTRODUCTION: While nicotine replacement therapy (NRT) is an effective pharmacological smoking cessation treatment, its efficacy is influenced by adherence to and consumption of the prescribed dose. The genetic variant rs1051730 in the nicotinic receptor gene cluster CHRNA5-A3-B4 influences smoking quantity. The aim of this study was to explore the impact of rs1051730 genotype on adherence to and consumption of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Alleles
Share to Medication Adherence
Share to Nicotine
Share to Nicotinic Agonists
Share to Receptors, Nicotinic
Share to Smoking Cessation
Share to Socioeconomic Factors
Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 25891233
DOI: 10.1016/j.drugalcdep.2015.03.035
PMCID: PMC4462564

Genes

CHRNA5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt.PMID 25891233Read ↗

Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.Semantic proximity Read ↗

Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.Semantic proximity Read ↗

Effect of the rs1051730-rs16969968 variant and smoking cessation treatment: a meta-analysis.Semantic proximity Read ↗

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.Semantic proximity Read ↗

Nicotinic Receptor Alpha-5 Subunit Gene Polymorphism is Associated With Heavy Smoking Under a Range of Nicotine Dosing Conditions.Semantic proximity Read ↗

Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.Semantic proximity Read ↗

Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes.Semantic proximity Read ↗

Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.Semantic proximity Read ↗

Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.Semantic proximity Read ↗

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.Semantic proximity Read ↗

A recall-by-genotype study of CHRNA5-A3-B4 genotype, cotinine and smoking topography: study protocol.Semantic proximity Read ↗

Variation in the α 5 nicotinic acetylcholine receptor subunit gene predicts cigarette smoking intensity as a function of nicotine content.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.